Vivimed Labs Limited (VIVIMEDLAB) — Financial Results
Vivimed Labs Limited clarified that its financial results for the year ended March 31, 2025 were submitted with a missing SEBI MD/CEO signature, a delayed filing due to a technical scanning issue within three hours, and discrepancies in XBRL submission requiring a revised filing. The company confirmed corrective actions and future procedural improvements to prevent recurrence.
About Vivimed Labs Limited (VIVIMEDLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when VIVIMEDLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track VIVIMEDLAB — Free💡 Ask AI about this filing
📊 More VIVIMEDLAB filings
- 🔴 Financial Results — 22 July 2026 Vivimed Labs Limited announced the publication of audited financial results for FY2026 in major news...
- share transfer — 22 July 2026 Vivimed Labs reported that its registrar, Aarthi Consultants, processed zero transfer requests for p...
- share transfer — 10 July 2026 Vivimed Labs Limited received a SEBI Regulation 74(5) compliance certificate from its RTA, Aarthi Co...
- Financial Results — 30 June 2026 Vivimed Labs Limited announced that its trading window will close on 01.07.2026 and remain closed un...
- 🔴 Announcement — 17 June 2026 Vivimed Labs Limited has initiated a Corporate Insolvency Resolution Process (CIRP) as disclosed in ...
🔥 Also filed on 25 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when VIVIMEDLAB files new disclosures
Track VIVIMEDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track VIVIMEDLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research